Related references
Note: Only part of the references are listed.Exon-skipping drug pulls ahead in muscular dystrophy field
Alisa Opar
NATURE MEDICINE (2012)
Ryanodine Receptor Oxidation Causes Intracellular Calcium Leak and Muscle Weakness in Aging
Daniel C. Andersson et al.
CELL METABOLISM (2011)
Diaphragm rescue alone prevents heart dysfunction in dystrophic mice
Alastair Crisp et al.
HUMAN MOLECULAR GENETICS (2011)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
One-year Treatment of Morpholino Antisense Oligomer Improves Skeletal and Cardiac Muscle Functions in Dystrophic mdx Mice
Bo Wu et al.
MOLECULAR THERAPY (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Genetic therapies for RNA mis-splicing diseases
Suzan M. Hammond et al.
TRENDS IN GENETICS (2011)
Chemical treatment enhances skipping of a mutated exon in the dystrophin gene
Atsushi Nishida et al.
NATURE COMMUNICATIONS (2011)
Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group
K. P. E. Glahn et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino
B. Wu et al.
GENE THERAPY (2010)
Guanine Analogues Enhance Antisense Oligonucleotide-induced Exon Skipping in Dystrophin Gene In Vitro and In Vivo
Yihong Hu et al.
MOLECULAR THERAPY (2010)
Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs
Toshifumi Yokota et al.
ANNALS OF NEUROLOGY (2009)
The influence of calcium signaling on the regulation of alternative splicing
Joachim Krebs
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Dosing Regimen Has a Significant Impact on the Efficiency of Morpholino Oligomer-Induced Exon Skipping in mdx Mice
Alberto Malerba et al.
HUMAN GENE THERAPY (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle
Andrew M. Bellinger et al.
NATURE MEDICINE (2009)
Identification of Small Molecule and Genetic Modulators of AON-Induced Dystrophin Exon Skipping by High-Throughput Screening
Debra A. O'Leary et al.
PLOS ONE (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Reference genes for normalization of gene expression studies in human osteoarthritic articular cartilage
Manuel Pombo-Suarez et al.
BMC MOLECULAR BIOLOGY (2008)
Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy
En Kimura et al.
HUMAN MOLECULAR GENETICS (2008)
Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene
Akinorl Nakamura et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Generation of human induced pluripotent stem cells from dermal fibroblasts
W. E. Lowry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human
Marcella Neri et al.
NEUROMUSCULAR DISORDERS (2007)
Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies
Chun-Hong Zhu et al.
AGING CELL (2007)
Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation
Chang-Hao Cui et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
Calcium release from ryanodine receptors in the nucleoplasmic reticulum
P Marius et al.
CELL CALCIUM (2006)
Pharmacotherapy of spasticity in children with cerebral palsy
A Verrotti et al.
PEDIATRIC NEUROLOGY (2006)
Dantrolene stabilizes domain interactions within the ryanodine receptor
S Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
P Sazani et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
QL Lu et al.
NATURE MEDICINE (2003)
Ryanodine receptor calcium release channels
M Fill et al.
PHYSIOLOGICAL REVIEWS (2002)
Recombinant micro-genes and dystrophin viral vectors
G Dickson et al.
NEUROMUSCULAR DISORDERS (2002)
Dantrolene inhibition of ryanodine receptor Ca2+ release channels -: Molecular mechanism and isoform selectivity
FY Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
